StockData
IRadimed Corp logo

IRadimed Corp (IRMD) income statement

IRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3054% above fair value
$82.31−1.14 (-1.37%)

Close on Nov 18, 2026Market cap $1.05BP/E 44.0Yield –

IRadimed Corp income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, TTM

Gross margin
75.5%
Operating margin
32.3%
Net margin
26.8%
Return on equity, FY2025
24.8%

Financial strength

Current ratio
8.99
Debt to equity
–
Debt to assets
–
Cash to current liabilities
613.1%

Valuation

P/E ratio
44.0
Price to sales
11.78
Price to book
9.89
Dividend yield
–

See a number that looks wrong?